clinical trial · NCT06643754
A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.·phase2·recruiting·n = 115
Advanced Solid TumorsSHR-3276
brief summary
This study is an open-label, multicenter Phase I/II clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-3276 for injection in patients with advanced solid tumors.
started
Dec 10, 2024
primary completion
Dec 30, 2027
completion
Dec 30, 2028
last updated
Jan 8, 2025
official title
A Phase I/II Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of SHR-3276 Injection in Patients With Advanced Malignant Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol